Anti-EGFR targeted therapy delivered before versus during radiotherapy in locoregionally advanced nasopharyngeal carcinoma: a big-data, intelligence platform-based analysis

Anti-EGFR targeted therapy delivered before versus during radiotherapy in locoregionally advanced nasopharyngeal carcinoma: a big-data, intelligence platform-based analysis

Abstract Background Little is known about the prognostic difference of anti-EGFR therapy, cetuximab (CTX) or nimotuzumab (NTZ), concurrently with induction chemotherapy (IC, investigational arm) or RT (control arm) for patients with locoregionally advanced nasopharyngeal carcinoma (LA-NPC). We condu...

Full description

Bibliographic Details
Main Authors: Hao Peng, Ling-Long Tang, Xu Liu, Lei Chen, Wen-Fei Li, Yan-Ping Mao, Yuan Zhang, Li-Zhi Liu, Li Tian, Ying Guo, Ying Sun, Jun Ma
Format: Article
Language:English
Published: BMC 2018-03-01
Series:BMC Cancer
Subjects:
Nasopharyngeal carcinoma
Induction chemotherapy
Cetuximab
Nimotuzumab
Intensity-modulated radiotherapy
Prognosis
Online Access:http://link.springer.com/article/10.1186/s12885-018-4268-y

Internet

http://link.springer.com/article/10.1186/s12885-018-4268-y

Similar Items